Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Angela Mc Rose*, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, Joaquin Baruch, Sarah Denayer, Lucie Seyler, Lisa Domegan, Odile Launay, Ausenda Machado, Cristina Burgui, Roberta Vaikutyte, F. Annabel Niessen, Isabela I. Loghin, Petr Husa, Nassera Aouali, George Panagiotakopoulos, Kristin Tolksdorf, Judit Krisztina HorváthJennifer Howard, Francisco Pozo, Virtudes Gallardo, Diana Nonković, Aušra Džiugytė, Nathalie Bossuyt, Thomas Demuyser, Róisín Duffy, Liem Binh Luong Nguyen, Irina Kislaya, Iván Martínez-Baz, Giedre Gefenaite, Mirjam J. Knol, Corneliu Popescu, Lenka Součková, Marc Simon, Stella Michelaki, Janine Reiche, Annamária Ferenczi, Concepción Delgado-Sanz, Zvjezdana Lovrić Makarić, John Paul Cauchi, Cyril Barbezange, Els Van Nedervelde, Joan O'Donnell, Christine Durier, Raquel Guiomar, Jesús Castilla, Indrė Jonikaite, Patricia Cjl Bruijning-Verhagen, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)
Research output: Contribution to journal › Article › Research › peer-review
11Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022'. Together they form a unique fingerprint.